Dexsol™
产品特征
Easy to handle
References:
1. Lackgren G, Lottman H, Hensle T, Stenberg A. Endoscopic treatment of vesioureteral reflux and urinary incontinence in children. AUA Update Series. 2003;22:294-299.
2. Lottmann HB, Margaryan M, Bernuy M, et al. The effect of endoscopic injections of dextranomer based on continence and bladder capacity: a prospective study of 31 patients. J Urol. 2002; 168:1663-1867.
3. Capozza N, Lais A, Matarazzo E, Nappo S, Patricolo M, Caione P. Treatment of vesico-ureteric reflux: a new algorithm based on parental preference. BJU International. 2003;92:285-288.
4. Capozza N, Caione P. Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: a randomized comparison with antibiotic prophylaxis. J Pediatr 2002; 140: 230-4.
5. Andrew J. Kirsch, Hal C. Scherz, at al. Hydro-distention implantation technique (HIT)-a novel endoscopic treatment for VUR in children and adults Contemporary Urology, April 2005.
有效性和安全性
“葡聚糖成分通过了临床实验上的有效性和安全性的检验。”
多次发表显示，10年以上使用葡聚糖的VUR治疗方法在长期安全性方面的认证研究结果。
在全世界有100,000名以上的儿童，接受施术后获得了完全康复，并且没有出现过持续性副作用的报告。
现在，使用葡聚糖的VUR治疗法，已经成为快速诊断和治疗患有多次复发性尿路感染的小儿患者，预防长期性肾脏损伤的有效的治疗方案。
References:
1. Capozza N, Caione P. Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: a randomized comparison with antibiotic prophylaxis. J Pediatr 2002; 140: 230-4.
2. Sjostrom S, Sillen U, Bachelard M, et al. Spontaneous resolution of high grade infantile vesicoureteral reflux. J Urol 2004; 172: 694-8.
